UROMITEXAN 100MG/ML INJ/INF SOL 15X4ML
Marketing resumed · Not specified
Active ingredient: MESNA
Medicine shortages: Czechia · Page 17
Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.
Data checked:
970 notices · Page 17 / 20
← Europe overviewNational authority sources: Czechia
Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.
Medicine shortages: Czechia · Page 17
VELAXIN 75MG CPS PRO 28
Unterbrechung des Inverkehrbringens · Capacity/distribution reasons
Active ingredient: VENLAFAXIN
AGNUCASTON TBL FLM 30
Marketing resumed · Not specified
Active ingredient: FYTOFARMAKA A ŽIVOČIŠNÉ PRODUKTY (ČESKÁ ATC SKUPINA)
AGOMELATINE GLENMARK 25MG TBL FLM 28
Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: AGOMELATIN
CARBOPLATIN KABI 10MG/ML INF CNC SOL 1X15ML+PLAST
Marketing resumed · Not specified
Active ingredient: KARBOPLATINA
DEXOKET 25MG POR GRA SOL 10
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: DEXKETOPROFEN
DIPIDOLOR 7,5MG/ML INJ SOL 10X(5X2ML)
Marketing resumed · Not specified
Active ingredient: PIRITRAMID
GLEPARK 0,18MG TBL NOB 100
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: PRAMIPEXOL
PHLOGENZYM 90MG/48MG/100MG TBL ENT 100 II
Marketing ended · Produktionsgründe
Active ingredient: TRYPSIN, KOMBINACE
PHLOGENZYM 90MG/48MG/100MG TBL ENT 100 III
Marketing ended · Produktionsgründe
Active ingredient: TRYPSIN, KOMBINACE
PHLOGENZYM 90MG/48MG/100MG TBL ENT 200 II
Marketing ended · Produktionsgründe
Active ingredient: TRYPSIN, KOMBINACE
PHLOGENZYM 90MG/48MG/100MG TBL ENT 200 III
Marketing ended · Produktionsgründe
Active ingredient: TRYPSIN, KOMBINACE
PHLOGENZYM 90MG/48MG/100MG TBL ENT 40 II
Marketing ended · Produktionsgründe
Active ingredient: TRYPSIN, KOMBINACE
PHLOGENZYM 90MG/48MG/100MG TBL ENT 40 III
Marketing ended · Produktionsgründe
Active ingredient: TRYPSIN, KOMBINACE
PHLOGENZYM 90MG/48MG/100MG TBL ENT 800
Marketing ended · Produktionsgründe
Active ingredient: TRYPSIN, KOMBINACE
PIRAMIL 1,25MG TBL NOB 30 I
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: RAMIPRIL
PRALUENT 150MG INJ SOL PEP 2X1ML II
Marketing resumed · Not specified
Active ingredient: ALIROKUMAB
PYZYPI 400MG TBL FLM 60
Marketing resumed · Not specified
Active ingredient: PAZOPANIB
SITAGLIPTIN GLENMARK 100MG TBL FLM 98
Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: SITAGLIPTIN
URAPIDIL STADA 60MG CPS PRO 50 I
Marketing resumed · Not specified
Active ingredient: URAPIDIL
VONILLE 0,06MG/0,015MG TBL FLM 3X28(24+4)
Marketing resumed · Not specified
Active ingredient: GESTODEN A ETHINYLESTRADIOL
AULIN 100MG POR GRA SUS 30 I
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: NIMESULID
BIGITAL 5MG/10MG TBL NOB 30
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: BISOPROLOL A AMLODIPIN
EFLUELDA INJ SUS ISP 1X0,5ML+SJ
Marketing resumed · Not specified
Active ingredient: CHŘIPKA, INAKTIVOVANÁ VAKCÍNA, ŠTĚPENÝ VIRUS NEBO POVRCHOVÝ ANTIGEN
FLOXAL 3MG/G OPH UNG 3G
Marketing resumed · Not specified
Active ingredient: OFLOXACIN
GLUKÓZA B. BRAUN 10% 100MG/ML INF SOL 10X500ML
Marketing resumed · Not specified
Active ingredient: CUKRY
INFLUVAC INJ SUS ISP 10X0,5ML+10J
Marketing resumed · Not specified
Active ingredient: CHŘIPKA, INAKTIVOVANÁ VAKCÍNA, ŠTĚPENÝ VIRUS NEBO POVRCHOVÝ ANTIGEN
SERETIDE DISKUS 50MCG/250MCG INH PLV DOS 1X60DÁV
Marketing ended · Change to another SÚKL code
Active ingredient: SALMETEROL A FLUTIKASON
TEZEFORT 80MG/10MG TBL NOB 28
Marketing resumed · Not specified
Active ingredient: TELMISARTAN A AMLODIPIN
TRITACE 10MG TBL NOB 30
Marketing ended · Commercial/marketing reasons
Active ingredient: RAMIPRIL
KRYPTOSCAN 74-2735MBQ RAD GEN 111MBQ
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: KRYPTON-(81MKR), PLYN
KRYPTOSCAN 74-2735MBQ RAD GEN 148MBQ
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: KRYPTON-(81MKR), PLYN
KRYPTOSCAN 74-2735MBQ RAD GEN 185MBQ
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: KRYPTON-(81MKR), PLYN
KRYPTOSCAN 74-2735MBQ RAD GEN 222MBQ
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: KRYPTON-(81MKR), PLYN
KRYPTOSCAN 74-2735MBQ RAD GEN 259MBQ
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: KRYPTON-(81MKR), PLYN
KRYPTOSCAN 74-2735MBQ RAD GEN 296MBQ
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: KRYPTON-(81MKR), PLYN
ULTRATAG RBC 96MCG RAD KIT 5X(1+2STŘ)
Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: TECHNECIUM-(99MTC) SN2+ ČINIDLA, PRO ZNAČENÍ BUNĚK
BETASERC 8MG TBL NOB 100
Marketing resumed · Not specified
Active ingredient: BETAHISTIN
BRAUNOL 75MG/G DRM SOL 1X100ML
Marketing resumed · Not specified
Active ingredient: JODOVANÝ POVIDON
CANDIBENE 10MG/ML DRM SPR SOL 1X40ML
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: KLOTRIMAZOL
CARBOPLATIN KABI 10MG/ML INF CNC SOL 1X5ML+PLAST
Unterbrechung des Inverkehrbringens · Capacity/distribution reasons
Active ingredient: KARBOPLATINA
CLINDAMYCIN KABI 150MG/ML INJ SOL/INF CNC SOL 10X2ML
Unterbrechung des Inverkehrbringens · Capacity/distribution reasons
Active ingredient: KLINDAMYCIN
EGILOK 25MG TBL NOB 60
Unterbrechung des Inverkehrbringens · Capacity/distribution reasons
Active ingredient: METOPROLOL
GLICLAZID MYLAN 30MG TBL MRL 120
Marketing ended · Change to another SÚKL code
Active ingredient: GLIKLAZID
IBALGIN 50MG/G GEL 100G
Marketing resumed · Not specified
Active ingredient: IBUPROFEN
IBALGIN DUO EFFECT 50MG/G+2MG/G CRM 100G
Marketing resumed · Not specified
Active ingredient: IBUPROFEN
LEFLUNOPHARM 10MG TBL FLM 30
Marketing resumed · Not specified
Active ingredient: LEFLUNOMID
LIPERTANCE 10MG/5MG/5MG TBL FLM 30
Marketing resumed · Not specified
Active ingredient: ATORVASTATIN, AMLODIPIN A PERINDOPRIL
LIPERTANCE 10MG/5MG/5MG TBL FLM 90(3X30)
Marketing resumed · Not specified
Active ingredient: ATORVASTATIN, AMLODIPIN A PERINDOPRIL
METFORMIN TEVA 1000MG TBL FLM 60 II
Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: METFORMIN